Cargando…

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome

Objective: To examine the time course of aqueous-deficient and meibomian gland dysfunction (MGD) in patients with primary Sjogren's Syndrome (pSS). Methods: This prospective study was conducted on pSS female patients in the Department of Rheumatism of the Second Affiliated Hospital, School of M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Qin, Qiyu, Liu, Bo, Fu, Yana, Lin, Lin, Huang, Xiaodan, Jin, Xiuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914862/
https://www.ncbi.nlm.nih.gov/pubmed/31921869
http://dx.doi.org/10.3389/fmed.2019.00291
_version_ 1783479898811138048
author Wang, Yi
Qin, Qiyu
Liu, Bo
Fu, Yana
Lin, Lin
Huang, Xiaodan
Jin, Xiuming
author_facet Wang, Yi
Qin, Qiyu
Liu, Bo
Fu, Yana
Lin, Lin
Huang, Xiaodan
Jin, Xiuming
author_sort Wang, Yi
collection PubMed
description Objective: To examine the time course of aqueous-deficient and meibomian gland dysfunction (MGD) in patients with primary Sjogren's Syndrome (pSS). Methods: This prospective study was conducted on pSS female patients in the Department of Rheumatism of the Second Affiliated Hospital, School of Medicine, Zhejiang University. The age-matched MGD female patients without pSS (non-SS-MGD) were recruited as MGD controls from the Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University. After providing written informed consent, the patients underwent an eye examination and completed an Ocular Surface Disease Index questionnaire that assessed the symptoms of dry eye disease. The subjects were evaluated using Schirmer I test (SIt), tear meniscus height (TMH), noninvasive keratographic break-up time (NIKBUT), corneal fluorescein staining (CFS), and meibomian gland evaluation (meibomian gland infrared, lid margin score, expressible meibomian glands number and the secretions quality). The patients were divided into two groups: early stage (≤3 years) and late stage (>3 years) according to their medical history of dry eye. The data were analyzed using SPSS 20.0. Results: There were 49 pSS and 52 non-SS-MGD female patients enrolled in this study from 1 January 2018 to 30 December 2018. There were no differences in age (49.38 ± 10.32 and 48.69 ± 13.57 years) and dry eye medical history (48.44 ± 40.16 and 47.79 ± 37.85 months) between the two groups. When the medical history was ≤3 years, the average SIt and TMH of the pSS patients were significantly smaller than those of the patients with MGD. However, the signs related to the MGD did not show a significant difference between the two groups. When the medical history was >3 years, both the SIt and TMH and the signs related to MGD in pSS group were significantly more severe than the MGD group. Conclusions: Our results demonstrated that 3 years may be an important time node for the dry eye development in pSS patients, before this, the lacrimal glands received a greater influence, and then the meibomian glands began to be greatly affected.
format Online
Article
Text
id pubmed-6914862
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69148622020-01-09 Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome Wang, Yi Qin, Qiyu Liu, Bo Fu, Yana Lin, Lin Huang, Xiaodan Jin, Xiuming Front Med (Lausanne) Medicine Objective: To examine the time course of aqueous-deficient and meibomian gland dysfunction (MGD) in patients with primary Sjogren's Syndrome (pSS). Methods: This prospective study was conducted on pSS female patients in the Department of Rheumatism of the Second Affiliated Hospital, School of Medicine, Zhejiang University. The age-matched MGD female patients without pSS (non-SS-MGD) were recruited as MGD controls from the Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University. After providing written informed consent, the patients underwent an eye examination and completed an Ocular Surface Disease Index questionnaire that assessed the symptoms of dry eye disease. The subjects were evaluated using Schirmer I test (SIt), tear meniscus height (TMH), noninvasive keratographic break-up time (NIKBUT), corneal fluorescein staining (CFS), and meibomian gland evaluation (meibomian gland infrared, lid margin score, expressible meibomian glands number and the secretions quality). The patients were divided into two groups: early stage (≤3 years) and late stage (>3 years) according to their medical history of dry eye. The data were analyzed using SPSS 20.0. Results: There were 49 pSS and 52 non-SS-MGD female patients enrolled in this study from 1 January 2018 to 30 December 2018. There were no differences in age (49.38 ± 10.32 and 48.69 ± 13.57 years) and dry eye medical history (48.44 ± 40.16 and 47.79 ± 37.85 months) between the two groups. When the medical history was ≤3 years, the average SIt and TMH of the pSS patients were significantly smaller than those of the patients with MGD. However, the signs related to the MGD did not show a significant difference between the two groups. When the medical history was >3 years, both the SIt and TMH and the signs related to MGD in pSS group were significantly more severe than the MGD group. Conclusions: Our results demonstrated that 3 years may be an important time node for the dry eye development in pSS patients, before this, the lacrimal glands received a greater influence, and then the meibomian glands began to be greatly affected. Frontiers Media S.A. 2019-12-10 /pmc/articles/PMC6914862/ /pubmed/31921869 http://dx.doi.org/10.3389/fmed.2019.00291 Text en Copyright © 2019 Wang, Qin, Liu, Fu, Lin, Huang and Jin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Yi
Qin, Qiyu
Liu, Bo
Fu, Yana
Lin, Lin
Huang, Xiaodan
Jin, Xiuming
Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title_full Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title_fullStr Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title_full_unstemmed Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title_short Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients With Primary Sjogren's Syndrome
title_sort clinical analysis: aqueous-deficient and meibomian gland dysfunction in patients with primary sjogren's syndrome
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914862/
https://www.ncbi.nlm.nih.gov/pubmed/31921869
http://dx.doi.org/10.3389/fmed.2019.00291
work_keys_str_mv AT wangyi clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT qinqiyu clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT liubo clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT fuyana clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT linlin clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT huangxiaodan clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome
AT jinxiuming clinicalanalysisaqueousdeficientandmeibomianglanddysfunctioninpatientswithprimarysjogrenssyndrome